FDA Preemption
Hatch-Waxman
Fifth Circuit
Demahy v. Actavis, Inc.
2008-31204
USDC ED Louisiana
Does Hatch-Waxman preempt Louisiana state-law failure-to-warn counts pursuant to 21 U.S.C. § 355(b)(1) et seq., 21 C.F.R. Part 12 314 and 57 Fed. Reg. 17950-1 given drug labels which appeared on the bottles for a NDA generic form of Reglan metoclopramide that allegedly manifested tardive dyskinesia in claimant?
Federal Preemption
FDCA Truth in Labeling
NLEA 21 U.S.C. § 343
Third Circuit
Holk v. Snapple Beverage Corporation
2008-3060
USDC New Jersey
After a defendant removed a class action lawsuit premised on alleged misleading beverage labels and advertising claims from state court to federal district court pursuant to the Class Action Fairness Act, 28 U.S.C. § 1453(b), could defendant thereafter compel dismissal of the civil suit under theories of federal agency preemption?
Download Stored Opinion
_____________________________________________________